Real-World Experience With the Expanded Access Program for 89Zr-Girentuximab PET in Small Renal Masses - R. Jonathan Henderson
Jonathan Henderson
Zachary Klaassen hosts Jonathan Henderson to discuss his experience with the Expanded Access Program for [89Zr]Zr-girentuximab PET imaging for small renal masses.
Neoadjuvant Pembrolizumab and Radiotherapy for Kidney Cancer - Muhammad Ali
Leslie Ballas speaks with Muhammad Ali about the NAPSTER trial, a phase two randomized study examining neoadjuvant stereotactic radiotherapy with or without pembrolizumab prior to nephrectomy for renal cell carcinoma.
